| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/08/2009 | EP2044954A1 Treatment of fungal infections |
| 04/08/2009 | EP2044940A2 Methods of treating patients suffering from movement disorders |
| 04/08/2009 | EP2043691A1 New paediatric indications for direct thrombin inhibitors |
| 04/08/2009 | EP2043659A1 Anti-cancer therapy comprising an h2-blocker, at least one antiinflammatory agent and a cytotoxic agent |
| 04/08/2009 | EP2043647A2 Controlled release formulations and associated methods |
| 04/08/2009 | EP2043641A2 Combinations of monoamine reuptake inhibitors and potassium channel activators |
| 04/08/2009 | EP2043614A2 Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient |
| 04/08/2009 | EP1814590B1 Treatment of obesity and related disorders |
| 04/08/2009 | EP1682122B9 Combinations of valsartan, amiloride or triamterine, and a diuretic |
| 04/08/2009 | EP1594499B1 Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer |
| 04/08/2009 | EP1461340B1 Trioxane derivatives as antimalaria or anticancer compounds |
| 04/08/2009 | EP1461015B1 Compositions containing both sedative and non-sedative antihistamines |
| 04/08/2009 | EP1441708B1 Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
| 04/08/2009 | EP1409076A4 Method and apparatus for treating tumors using low strength electric fields |
| 04/08/2009 | EP1210092B1 Calcium-containing structures and methods of making and using the same |
| 04/08/2009 | EP0961612B1 Protein stabilized pharmacologically active agents and their use |
| 04/08/2009 | EP0877758B1 PURIFIED SR-p70 PROTEIN |
| 04/08/2009 | CN101404988A Breast cancer treatment regimen |
| 04/08/2009 | CN101402955A Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 04/08/2009 | CN101401938A Neutralizing human anti-IGFR antibody |
| 04/08/2009 | CN100475953C Pancreatic stem cells |
| 04/08/2009 | CN100475829C Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| 04/08/2009 | CN100475816C Reverse-turn mimetics and method relating thereto |
| 04/08/2009 | CN100475757C Substance for use in dietary supplementation or for prepn. of medicament for treating non-insulin dependent diabetes mellitus, Hypertension and/or metabolic syndrome |
| 04/08/2009 | CN100475221C A composition (RCUD) for protecting and/or repairing DNA from oxidative damages and a method thereof |
| 04/08/2009 | CN100475190C Implantation slow release medicine in eyes |
| 04/08/2009 | CN100475182C Composition for preventive treatment of herpessimplex |
| 04/07/2009 | US7514574 Biodegradable penetration enhancers with multiple hydrophilic moieties |
| 04/07/2009 | US7514546 Antibodies |
| 04/07/2009 | US7514472 Fat or oil composition |
| 04/07/2009 | US7514471 2S)-3-(4-{2-[(Cyclohexylmethyl)(heptyl)amino]-2-oxoethoxy}phenyl)-2-ethoxypropanoic acid; treating lipid disorders (dyslipidemias), insulin resistance |
| 04/07/2009 | US7514415 Suppressing an immune response in rheumatoid arthritis by administering a pure or isolated oligodeoxynucleotide of up to 100 nucleotides in length along with an additional antiinflammatory agent, immunosuppressive agent or antiarthritis agent |
| 04/07/2009 | US7514414 Autoimmune disease; bactericides, viricides, fungicides, parasiticides |
| 04/07/2009 | US7514413 Combination of ATP-depleting agents (mitochondrial ATP-inhibitor, a methylthioadenosine phosphorylase inhibitor or an inhibitor of De Novo purine synthesis); chemotherapy |
| 04/07/2009 | US7514405 Method involves administering a therapeutically effective amount of Serp-1, its analogs, and biologically active fragments thereof in combination with an anti-rejection agent, such as cyclosporin, and a pharmaceutically acceptable |
| 04/07/2009 | US7514259 Derived from the neuroretina of the eye ex vivo and in vivo |
| 04/07/2009 | US7514239 Nucleotide sequences coding polypeptide for use in the treatment of preferential glandular disorders |
| 04/07/2009 | US7514225 detecting drugs that inhibits the binding of macrophage migration inhibitory factor (MIF) to an antimacrophage migration inhibitor factor monoclonal or polyclonal antibody; drug screening |
| 04/07/2009 | US7514208 Methods for identifying modulators of cyclic nucleotide-gated cation channels |
| 04/07/2009 | US7514107 Treatment of diseases involving defective gap junctional communication |
| 04/07/2009 | US7514105 Bioavailability/bioefficacy enhancing activity of Cuminum cyminum and extracts and fractions thereof |
| 04/07/2009 | US7514087 Administering primer and boosting composition comprising source of one or more CD8+ T cell epitopes of melanoma from a source of non-replicating or replication-deficient recombinant poxvirus vector in the human |
| 04/07/2009 | US7514073 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders |
| 04/07/2009 | US7514072 Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia |
| 04/07/2009 | CA2490152C Oxazole derivatives and their use as insulin sensitizers |
| 04/07/2009 | CA2413190C Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 04/07/2009 | CA2410065C Micellar pharmaceutical compositions for buccal and pulmonary application |
| 04/07/2009 | CA2387888C Local prevention or amelioration of pain from surgically closed wounds |
| 04/07/2009 | CA2372384C Anti-inflammatory bioactive glass particulates |
| 04/07/2009 | CA2297097C Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches |
| 04/07/2009 | CA2204652C Composition for prevention and treatment of hiv-1 infection comprising at least two different hiv-1 reverse transcriptase inhibitors |
| 04/02/2009 | WO2009042542A1 Benzoquinone derivative e3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis |
| 04/02/2009 | WO2009042395A1 Compositions comprising quinolone and methods for treating or controlling infections |
| 04/02/2009 | WO2009042166A1 Liquid bevirimat dosage forms for oral administration |
| 04/02/2009 | WO2009040394A1 Use of a combination of an opioid agonist and an opioid antagonist for the treatment of crohn´s disease and the symptoms associated with crohn´s disease |
| 04/02/2009 | WO2009012425A3 Compositions including leukotriene antagonists and nsaids and methods of using the same |
| 04/02/2009 | WO2009010492A3 Combinations comprising telmisartan and an anticholinergic such as tiotropium or a glycopyrronium salt for the treatment of respiratory diseases such as copd or asthma |
| 04/02/2009 | WO2005082003A3 Peptides and uses thereof |
| 04/02/2009 | WO2005067632A3 Lipid compositions and use thereof |
| 04/02/2009 | WO2005020908A3 Selective inhibitors of stat-3 activation and uses thereof |
| 04/02/2009 | WO2004110358A3 Polymeric conjugates for tissue activated drug delivery |
| 04/02/2009 | US20090088464 Merged ion channel modulating compounds and Uses Thereof |
| 04/02/2009 | US20090088423 Methods and compositions for treating bacterial infections and diseases associated therewith |
| 04/02/2009 | US20090088408 Pharmaceutical compositions on anticholinergics, corticosteroids and betamimetics |
| 04/02/2009 | US20090087905 VEGF-D polynucleotides and methods of use |
| 04/02/2009 | US20090087503 Use of anabolic agents, anti-catabolic agents, antioxidant agents and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| 04/02/2009 | US20090087482 Temperature-Sensitive Liposomal Formulation |
| 04/02/2009 | US20090087440 Methods for Treating Cancer |
| 04/02/2009 | US20090087429 IL-17 homologous polypeptides and therapeutic uses thereof |
| 04/02/2009 | US20090087423 Novel protein complex and use thereof |
| 04/02/2009 | US20090087412 Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression |
| 04/02/2009 | US20090087409 Viral Polymerase Inhibitors |
| 04/02/2009 | US20090087405 Use of Lck inhibitors for treatment of immunologic diseases |
| 04/02/2009 | US20090087403 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 04/02/2009 | US20090087389 Dehydroepiandrosterone sulfate dihydrate inhalation compositions and methods |
| 04/02/2009 | DE202009000358U1 Lokalanästhetikum zur Linderung von Brustschmerz Local anesthetic to relieve chest pain |
| 04/02/2009 | CA2700365A1 Benzoquinone derivative e3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis |
| 04/02/2009 | CA2700242A1 Use of a combination of an opioid agonist and an opioid antagonist for the treatment of crohn's disease and the symptoms associated with crohn's disease |
| 04/01/2009 | EP2042596A1 Polypeptides involved in immune response |
| 04/01/2009 | EP2042509A1 Modulators of the function of FAS receptors and other proteins |
| 04/01/2009 | EP2042194A2 Treatment of refractory human tumors with epidermal growth factor receptor antagonists |
| 04/01/2009 | EP2042188A1 Pharmaceutical composition for treating or preventing hcv infection |
| 04/01/2009 | EP2042182A1 Pharmaceutical composition comprising arsenite for the treatment of malignancy |
| 04/01/2009 | EP2042181A1 Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases |
| 04/01/2009 | EP2042178A1 Ocular formulations comprising 5-chlorouracil and use thereof |
| 04/01/2009 | EP2042177A1 Use of a combination of an opioid agonist and an opioid antagonist for the treatment of Crohn's disease and the symptoms associated with Crohn's disease |
| 04/01/2009 | EP2042176A1 Use of a combination of an opioid agonist and an opioid antagonist for the treatment of Crohn's disease |
| 04/01/2009 | EP2042168A1 Inhalation device comprising phenethanolamine derivatives for treatment of respiratory diseases |
| 04/01/2009 | EP2040801A1 Method for reducing spasms comprising treatment with an agent that elevates the level of one or more cyclic nucleotides in the muscle |
| 04/01/2009 | EP2040755A1 Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity |
| 04/01/2009 | EP2040754A1 Use of adipose-tissue cell fractions for post-irradiation tissue regeneration |
| 04/01/2009 | EP2040753A2 Progastrin inhibitors in the treatment of colon cancer |
| 04/01/2009 | EP2040750A2 Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta t cell activators |
| 04/01/2009 | EP2040735A2 Cationic milk proteins for treating mastitis |
| 04/01/2009 | EP2040707A2 Combination of hmg-coa reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases |
| 04/01/2009 | EP2040689A2 Solution and method to reduce, treat and/or prevent oxidative stress and cell activation |
| 04/01/2009 | EP1824515B1 Treatment of dermatitis with dehydroepiandrosterone-glucocorticoid combinations |
| 04/01/2009 | EP1472375B1 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 04/01/2009 | EP1446425B1 Treatment of micro-organism infection |
| 04/01/2009 | EP1427825B1 Cdna encoding the human alpha2 delta4 calcium channel subunit |